- Home
- OR vs PCVX Comparison
OR vs PCVX Comparison
Compare OR & PCVX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OR
- PCVX
- Stock Information
- Founded
- OR 2014
- PCVX 2013
- Country
- OR Canada
- PCVX United States
- Employees
- OR N/A
- PCVX N/A
- Industry
- OR Precious Metals
- PCVX Biotechnology: Pharmaceutical Preparations
- Sector
- OR Basic Materials
- PCVX Health Care
- Exchange
- OR Nasdaq
- PCVX Nasdaq
- Market Cap
- OR 4.9B
- PCVX 4.4B
- IPO Year
- OR N/A
- PCVX 2020
- Fundamental
- Price
- OR $26.03
- PCVX $33.25
- Analyst Decision
- OR Strong Buy
- PCVX Strong Buy
- Analyst Count
- OR 3
- PCVX 10
- Target Price
- OR $23.00
- PCVX $136.50
- AVG Volume (30 Days)
- OR 794.7K
- PCVX 1.5M
- Earning Date
- OR 08-05-2025
- PCVX 08-05-2025
- Dividend Yield
- OR 0.74%
- PCVX N/A
- EPS Growth
- OR N/A
- PCVX N/A
- EPS
- OR 0.16
- PCVX N/A
- Revenue
- OR $201,026,000.00
- PCVX N/A
- Revenue This Year
- OR $61.88
- PCVX N/A
- Revenue Next Year
- OR $6.54
- PCVX N/A
- P/E Ratio
- OR $158.58
- PCVX N/A
- Revenue Growth
- OR 9.09
- PCVX N/A
- 52 Week Low
- OR $15.72
- PCVX $27.66
- 52 Week High
- OR $27.60
- PCVX $121.06
- Technical
- Relative Strength Index (RSI)
- OR 55.74
- PCVX 45.61
- Support Level
- OR $25.14
- PCVX $32.00
- Resistance Level
- OR $26.23
- PCVX $34.63
- Average True Range (ATR)
- OR 0.59
- PCVX 1.33
- MACD
- OR -0.12
- PCVX -0.06
- Stochastic Oscillator
- OR 58.26
- PCVX 33.67
About OR Osisko Gold Royalties Ltd
OR Royalties Inc, formerly Osisko Gold Royalties Ltd is engaged in the business of acquiring and managing precious metal and other high-quality royalties, streams and similar interests. The Company owns a portfolio of royalties, streams, offtakes, options on royalty/stream financings and exclusive rights to participate in future royalty/stream financings on various projects. Geographically, it generates majority of its income from North America and also generates some portions of income from South America, Australia, Africa and Europe.
About PCVX Vaxcyte Inc.
Vaxcyte Inc is a clinical-stage vaccine innovation company engineering high-fidelity vaccines to protect humankind from the consequences of bacterial diseases. It is developing broad-spectrum conjugate and novel protein vaccines to prevent or treat bacterial infectious diseases. Its product comprises of Pneumococcal conjugate vaccine. The firm's product candidate consists of VAX-31, VAX-24, VAX-A1, VAX-PG, VAX-GI, and Others.